Skip to main content
Molecular Therapy. Nucleic Acids logoLink to Molecular Therapy. Nucleic Acids
. 2020 Sep 10;22:166. doi: 10.1016/j.omtn.2020.08.026

Context Dependent Effects of Chimeric Peptide Morpholino Conjugates Contribute to Dystrophin Exon-skipping Efficiency

HaiFang Yin , Prisca Boisguerin, Hong M Moulton, Corinne Betts, Yiqi Seow, Jordan Boutilier, Qingsong Wang, Anthony Walsh, Bernard Lebleu, Matthew JA Wood ∗∗
PMCID: PMC7494604  PMID: 32920261

(Mol Ther Nucleic Acids. 2, e124; September 24, 2013)

The authors have discovered that the original article has errors in Figure 1 that were introduced when a graduate student used the wrong shared image folder when putting together the figures.

In the original Figure 1b, which shows expression of dystrophin-positive fibers in body-wide muscles, control images for wild-type C57 and untreated mdx mice were repeatedly used instead of the right images corresponding to the mice used for this manuscript. A corrected Figure 1b now appears below. This correction does not change the conclusions of the paper and the authors apologize for the error and any confusion they may have caused.

Figure 1b.

Figure 1b

Systemic administration of 9-B-PMO and B-9-PMO conjugates in adult mdx mice

Contributor Information

HaiFang Yin, Email: haifangyin@tmu.edu.cn.

Matthew J.A. Wood, Email: matthew.wood@dpag.ox.ac.uk.


Articles from Molecular Therapy. Nucleic Acids are provided here courtesy of The American Society of Gene & Cell Therapy

RESOURCES